Viewing Study NCT01638520


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-07-02 @ 10:12 PM
Study NCT ID: NCT01638520
Status: UNKNOWN
Last Update Posted: 2017-04-04
First Post: 2012-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis
Sponsor: National University Hospital, Singapore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis, Pulmonary View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune Therapy View
None Interleukin 4 View
None monoclonal antibody View